Inventor · disambiguated record
Clare Lloyd
Also filed as: LLOYD CLARE · LLOYD CLARE M
1 granted patent·10 pending applications·3 citations·filing 2000–2023
22Inventor score
Top patents by PatentIndex Score
11 records- 0162US6733990B1Nucleic acid encoding 15571, a GPCR-like molecule of the secretin-like familyMILLENNIUM PHARM INC·Filed 2000·Granted May 11, 2004·3 cites·12 claims
- 0260US2009226450A1Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses thereforMILLENNIUM PHARM INC·Filed 2009·Application pending·0 cites
- 0354US2009041752A1Compositions and methods for the treatment and diagnosis of immune disordersMILLENNIUM PHARM INC·Filed 2007·Application pending·0 cites
- 0454US2007281306A1Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses thereforMILLENNIUM PHARM INC·Filed 2006·Application pending·0 cites
- 0552US2025205188A1Treatment or prevention of respiratory diseases characterised by, or involving, lung fibrosisIMPERIAL COLLEGE INNOVATIONS LTD·Filed 2023·Application pending·0 cites
- 0648US2003069196A1Compositions and methods for the treatment and diagnosis of immune disordersMILLENNIUM PHARM INC·Filed 2001·Application pending·0 cites
- 0747US2011171205A1Novel 15571, 2465, 14266, 2882, 52871, 8203 and 16852 molecules and uses thereforMILLENNIUM PHARM INC·Filed 2011·Application pending·0 cites
- 0846US2005119209A1Compositions and methods for the treatment and diagnosis of immune disordersMILLENNIUM PHARM INC·Filed 2004·Application pending·0 cites
- 0944US2012171204A1Compositions and methods for the treatment and diagnosis of immune disordersLEVINSON DOUGLAS ADAM·Filed 2011·Application pending·0 cites
- 1043US2011123548A1Compositions and methods for the treatment and diagnosis of immune disordersMILLENNIUM PHARM INC·Filed 2010·Application pending·0 cites
- 1141US2024050389A1Treatment of idiopathic pulmonary fibrosisIMPERIAL COLLEGE INNOVATIONS LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Clare Lloyd files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →